![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](cs2014contents.gif)
Acta Cryst. (2006). E62, o4270-o4271 [ doi:10.1107/S1600536806033277 ]
Abstract: The title compound [systematic name: (7aS*,13aR*,13bR*,13cS*)-10-oxo-dodecahydro-1H,5H,8H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridinium 3-methyl-4-nitro-1-(4-nitrophenyl)-5-oxo-2-pyrazolinate 0.28-hydrate], C15H25N2O+·C10H7N4O5-·0.28H2O, consists of one matrinium cation [matrine is (7aS,13aR,13bR,13cS)-dodecahydro-1H,5H,8H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one], one picrolonate anion and 0.28 water molecules, held together by N-H
O and O-H
O hydrogen bonds. Disordered C atoms in the ring bearing the carbonyl group of the matrinium cation cause the ring to appear in half-chair and half-boat conformations.
Online 6 September 2006
Copyright © International Union of Crystallography
IUCr Webmaster